TY - JOUR
T1 - Low-grade carotid artery stenosis is associated with progression of brain atrophy and cognitive decline. The SMART-MR study
AU - Ghaznawi, Rashid
AU - Vonk, Jet Mj
AU - Zwartbol, Maarten Ht
AU - Bresser, Jeroen de
AU - Rissanen, Ina
AU - Hendrikse, Jeroen
AU - Geerlings, Mirjam I
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for this paper was received as part of a grant from the Netherlands Organization for Scientific Research-Medical Sciences (NWO-MW: project No. 904-65-095). This funding source had no role in the design, data collection, data analyses and data interpretation of the study or writing of the report. We also gratefully acknowledge the funding from the European Research Council under the European Union’s Horizon 2020 Programme (H2020)/ERC grant agreement n°637024 and n°66681 (SVDs@target). Acknowledgements
Publisher Copyright:
© The Author(s) 2022.
PY - 2023/2
Y1 - 2023/2
N2 - Asymptomatic low-grade carotid artery stenosis (LGCS) is a common finding in patients with manifest arterial disease, however its relationship with brain MRI changes and cognitive decline is unclear. We included 902 patients (58 ± 10 years; 81% male) enrolled in the Second Manifestations of Arterial Disease - Magnetic Resonance (SMART-MR) study without a history of cerebrovascular disease. LGCS was defined as 1-49% stenosis on baseline carotid ultrasound, whereas no LGCS (reference category) was defined as absence of carotid plaque. Brain and white matter hyperintensity (WMH) volumes and cognitive function were measured at baseline and after 4 (n = 480) and 12 years (n = 222) of follow-up. Using linear mixed-effects models, we investigated associations of LGCS with progression of brain atrophy, WMH, and cognitive decline. LGCS was associated with greater progression of global brain atrophy (estimate -0.03; 95%CI, -0.06 to -0.01;
p = 0.002), and a greater decline in executive functioning (estimate -0.02; 95%CI, -0.031 to -0.01;
p < 0.001) and memory (estimate -0.012; 95%CI, -0.02 to -0.001;
p = 0.032), independent of demographics, cardiovascular risk factors, and incident brain infarcts on MRI. No association was observed between LGCS and progression of WMH. Our results indicate that LGCS may represent an early marker of greater future brain atrophy and cognitive decline.
AB - Asymptomatic low-grade carotid artery stenosis (LGCS) is a common finding in patients with manifest arterial disease, however its relationship with brain MRI changes and cognitive decline is unclear. We included 902 patients (58 ± 10 years; 81% male) enrolled in the Second Manifestations of Arterial Disease - Magnetic Resonance (SMART-MR) study without a history of cerebrovascular disease. LGCS was defined as 1-49% stenosis on baseline carotid ultrasound, whereas no LGCS (reference category) was defined as absence of carotid plaque. Brain and white matter hyperintensity (WMH) volumes and cognitive function were measured at baseline and after 4 (n = 480) and 12 years (n = 222) of follow-up. Using linear mixed-effects models, we investigated associations of LGCS with progression of brain atrophy, WMH, and cognitive decline. LGCS was associated with greater progression of global brain atrophy (estimate -0.03; 95%CI, -0.06 to -0.01;
p = 0.002), and a greater decline in executive functioning (estimate -0.02; 95%CI, -0.031 to -0.01;
p < 0.001) and memory (estimate -0.012; 95%CI, -0.02 to -0.001;
p = 0.032), independent of demographics, cardiovascular risk factors, and incident brain infarcts on MRI. No association was observed between LGCS and progression of WMH. Our results indicate that LGCS may represent an early marker of greater future brain atrophy and cognitive decline.
KW - Brain atrophy
KW - cognitive decline
KW - cohort studies
KW - low-grade carotid artery stenosis
KW - white matter hyperintensity
UR - http://www.scopus.com/inward/record.url?scp=85140035664&partnerID=8YFLogxK
U2 - 10.1177/0271678X221133859
DO - 10.1177/0271678X221133859
M3 - Article
C2 - 36250500
SN - 0271-678X
VL - 43
SP - 309
EP - 318
JO - Journal of Cerebral Blood Flow and Metabolism
JF - Journal of Cerebral Blood Flow and Metabolism
IS - 2
ER -